Innovative Medicines for Luxembourg ASBL
Budget
€100 — €0
EP Access
2
accredited persons
Staff
3
1.6 FTE
EU Grants
None
Mission & Goals
The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation and ensures that patients benefi t from the latest medical advances. Engaging with national and European stakeholders, IML advocates for policies that support pharmaceutical research, market access, and a strong healthcare ecosystem. By facilitating dialogue between industry, policymakers, and healthcare professionals, IML contributes to shaping a dynamic and innovation-driven pharmaceutical landscape in Luxembourg, ensuring sustainable access to cutting-edge treatments.
EU Legislative Interests
EU Pharmaceutical Package, Critical Medicines Act, UWWTD
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EFPIA pharma.be letzpact.lu
Organisation Members
https://www.iml.lu/en/about-us/members
Commissioner Meetings
No recorded meetings with EU commissioners.